Profluent Bio is an AI-first protein design company creating new proteins and gene-editing tools for medicine, agriculture, and science.
Profluent Bio has raised $106.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Profluent Bio's investors include Insight Partners, Spark Capital, AIX Ventures, Air Street Capital, Bezos Expeditions.
Profluent Bio is headquartered in Berkeley, United States.
Profluent Bio is an AI-first protein design company creating new proteins and gene-editing tools for medicine, agriculture, and science.
Profluent Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Profluent Bio — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/profluent-bio. Accessed July 20, 2026.
VCBacked. (2025). Profluent Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/profluent-bio
{{cite web |title=Profluent Bio — Funding & Investors |url=https://www.vcbacked.co/company/profluent-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated